Research Publications
Reporting Quality in Health Economic Evaluation Studies of Immune Checkpoint Inhibitors: A Systematic Review. Yoshioka T, Azuma S, Funada S, Itaya T, Goto R. Clin Drug Investig. 2025 Mar 27.
Association of gambling activities and modalities with problem gambling in Japan: A nationwide cross-sectional online survey-based study. Yoshioka T, So R, Noda T, Kido M, Ito C, Nakaya T, Funada S, Tsutsumi S, Tabuchi T. Addict Behav Rep. 2025 Mar 1;21:100595.
Cost-effectiveness of AI-based diabetic retinopathy screening in nationwide health checkups and diabetes management in Japan: A modeling study. Akune Y, Kawasaki R, Goto R, Tamura H, Hiratsuka Y, Yamada M. Diabetes Res Clin Pract. 2025 Jan 30:112015.
Health utility value of overactive bladder in Japanese older adults. Takashi Yoshioka, Kenji Omae, Satoshi Funada, Tetsuji Minami, Rei Goto. BJUI Compass. 2024 Nov 24.
The estimation of healthcare cost of kidney transplantation in Japan using large-scale administrative databases. Hasegawa M, Kato H, Yoshioka T, Goto R. Clin Exp Nephrol. 2024 Nov 20.
A cost-effectiveness analysis of three surgical options for treating displaced femoral neck fractures in active older patients in Japan: A full economic evaluation. Yokoyama K, Akune Y, Katoh H, Bito S, Fujita Y, Goto R, Yamauchi K. PLoS One. 2024 Oct 29;19(10):e0310974.
Trends in the integration of medical corporation hospitals in Japan: a national wide longitudinal study between 2017 and 2021. Funada S, Luo Y, Kato H, Yoshioka T, Uno S, Honda K, Akune Y, Goto R.
BMC Health Serv Res. 2024 Aug 29;24(1):1005.
Association of night-shift work with gambling and problem gambling among workers in Japan: A nationwide cross-sectional study. T Yoshioka, R So, S Funada, S Tsutsumi, T Nakaya, R Okubo, T Minami, T Tabuchi. Addictive Behaviors, 2024 Sep,156:108071.
Cost-effectiveness of behavioural counselling intervention compared with non-intervention for adult patients with metabolic syndrome to prevent cardiovascular diseases and type 2 diabetes in Japan: a microsimulation modelling study. Akune Y, Anezaki H, Nakao YM, Goto R. BMJ Open. 2024 Apr 5;14(4):e072688. doi: 10.1136/bmjopen-2023-072688.
Cost-Effectiveness of School Urinary Screening for Early Detection of IgA Nephropathy in Japan. Honda K, Akune Y, Goto R. JAMA Netw Open. 2024 Feb 5;7(2):e2356412. doi: 10.1001/jamanetworkopen.2023.56412.
Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study. Uno S, Goto R, Honda K, Tokuda M, Kamata H, Chubachi S, Yamamoto R, Sato Y, Homma K, Uchida S, Namkoong H, Uwamino Y, Sasaki J, Fukunaga K, Hasegawa N. Cost Eff Resour Alloc. 2023 Jul 16;21(1):43. doi: 10.1186/s12962-023-00453-9.
The cost-effectiveness of universal asymptomatic preoperative SARS-CoV-2 PCR screening: a cost-utility analysis. Uno S, Goto R, Honda K, Uchida S, Uwamino Y, Namkoong H, Yoshifuji A, Mikita K, Takano Y, Matsumoto M, Kitagawa Y, Hasegawa N. Clin Infect Dis. 2023 Aug 9:ciad463. doi: 10.1093/cid/ciad463.
Detection bias in open-label trials of anticancer drugs: a meta-epidemiological study. Funada S, Luo Y, Kataoka Y, Yoshioka T, Fujita Y, Yoshida S, Katsura M, Tada M, Nishioka N, Nakamura Y, Ueno K, Uozumi R, Furukawa TA. BMJ Evid Based Med. 2023 Aug 16:bmjebm-2023-112332. doi: 10.1136/bmjebm-2023-112332.
Global Trends in Highly Cited Studies in COVID-19 Research. Funada S, Yoshioka T, Luo Y, Iwama T, Mori C, Yamada N, Yoshida H, Katanoda K, Furukawa TA. JAMA Netw Open. 2023 Sep 5;6(9):e2332802. doi: 10.1001/jamanetworkopen.2023.32802.